Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma.


Journal

Endocrine-related cancer
ISSN: 1479-6821
Titre abrégé: Endocr Relat Cancer
Pays: England
ID NLM: 9436481

Informations de publication

Date de publication:
09 2020
Historique:
received: 12 05 2020
accepted: 14 05 2020
pubmed: 23 7 2020
medline: 26 8 2021
entrez: 23 7 2020
Statut: ppublish

Résumé

Postoperative hypotension frequently occurs after resection of pheochromocytoma and/or paraganglioma (PPGLs). Epidural anesthesia (EA) is often used for pain control in open resection of these tumors; one of its side effects is hypotension. Our aim is to determine if EA is associated with an increased risk of postoperative hypotension after open resection of PPGLs. We conducted a retrospective review of patients who underwent open resection of PPGLs at the National Institutes of Health from 2004 to 2019. Clinical and perioperative parameters were analyzed by the use of EA. The primary endpoint was postoperative hypotension. Ninety-seven patients (46 female and 51 male; mean age, 38.5 years) underwent open resection of PPGLs and 69 (71.1%) received EA. Patients with EA had a higher rate beta-blocker use (79.7% vs 57.1%, P = 0.041), metastasis (69.6% vs 39.3%, P = 0.011), and were more frequently hypotensive after surgery (58.8% vs 25.0%, P = 0.003) compared to those without EA. Patients with postoperative hypotension had higher plasma normetanephrines than those without (7.3 fold vs 4.1 fold above the upper limit of normal, P = 0.018). Independent factors associated with postoperative hypotension include the use of beta-blockers (HR = 3.35 (95% CI: 1.16-9.67), P = 0.026) and EA (HR = 3.49 (95% CI: 1.25-9.76), P = 0.017). Data from this retrospective study suggest that, in patients with open resection of PPGLs, EA is an independent risk factor for early postoperative hypotension. Special caution is required in patients on beta-blockade. A prospective evaluation with standardized protocols for the use of EA and management of hemodynamic variability is necessary.

Identifiants

pubmed: 32698142
doi: 10.1530/ERC-20-0139
pii: ERC-20-0139.R2
pmc: PMC7482424
mid: NIHMS1624480
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

519-527

Subventions

Organisme : Intramural NIH HHS
ID : ZIA HD008735
Pays : United States

Références

Am J Cardiol. 2004 May 6;93(9A):7B-12B
pubmed: 15144930
Urology. 2017 Feb;100:131-138
pubmed: 27769919
Mayo Clin Proc. 1983 Dec;58(12):802-4
pubmed: 6645626
Drugs. 2015 Aug;75(12):1349-71
pubmed: 26177892
Acta Anaesthesiol Scand. 1992 Aug;36(6):554-8
pubmed: 1514341
Vasc Health Risk Manag. 2012;8:307-22
pubmed: 22661898
PLoS One. 2018 Feb 21;13(2):e0192924
pubmed: 29466473
J Clin Endocrinol Metab. 2014 Jun;99(6):1915-42
pubmed: 24893135
Can J Cardiol. 2014 May;30(5 Suppl):S9-S15
pubmed: 24684855
J Clin Endocrinol Metab. 2007 Nov;92(11):4069-79
pubmed: 17989126
J Clin Endocrinol Metab. 2010 Feb;95(2):678-85
pubmed: 19965926
Breast J. 2001 May-Jun;7(3):184-8
pubmed: 11469933
Int J Surg. 2017 Oct;46:1-6
pubmed: 28803996
Curr Hypertens Rep. 2017 Mar;19(3):22
pubmed: 28283926
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1464-1472
pubmed: 30289609
Curr Hypertens Rep. 2007 Aug;9(4):269-77
pubmed: 17686376
Anesthesiology. 1992 Jun;76(6):906-16
pubmed: 1599111
Ann Surg. 2001 Oct;234(4):560-9; discussion 569-71
pubmed: 11573049
J Endocrinol Invest. 2009 Mar;32(3):234-7
pubmed: 19542740
Lancet. 2005 Aug 20-26;366(9486):665-75
pubmed: 16112304

Auteurs

Douglas Wiseman (D)

National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

James D McDonald (JD)

National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Dhaval Patel (D)

National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Electron Kebebew (E)

Stanford University School of Medicine, Stanford, California, USA.

Karel Pacak (K)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.

Naris Nilubol (N)

National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH